Molecular biology of the Androgen receptorGELMANN, Edward P.Journal of clinical oncology. 2002, Vol 20, Num 13, pp 3001-3015, issn 0732-183XArticle

The ubiquitin-proteasome pathway and its role in cancerMANI, Aparna; GELMANN, Edward P.Journal of clinical oncology. 2005, Vol 23, Num 21, pp 4776-4789, issn 0732-183X, 14 p.Article

Inflammatory Cytokines Induce Phosphorylation and Ubiquitination of Prostate Suppressor Protein NKX3.1MARKOWSKI, Mark C; CAI BOWEN; GELMANN, Edward P et al.Cancer research (Chicago, Ill.). 2008, Vol 68, Num 17, pp 6896-6901, issn 0008-5472, 6 p.Article

Expression of NKX3.1 in normal and malignant tissuesGELMANN, Edward P; BOWEN, Cai; BUBENDORF, Lukas et al.The Prostate. 2003, Vol 55, Num 2, pp 111-117, issn 0270-4137, 7 p.Article

β-catenin affects androgen receptor transcriptional activity and ligand specificityTRUICA, Cristina I; BYERS, Stephen; GELMANN, Edward P et al.Cancer research (Baltimore). 2000, Vol 60, Num 17, pp 4709-4713, issn 0008-5472Article

Androgen blocks apoptosis of hormone-dependent prostate cancer cellsKIMURA, Kotohiko; MARKOWSKI, Mark; BOWEN, Cai et al.Cancer research (Baltimore). 2001, Vol 61, Num 14, pp 5611-5618, issn 0008-5472Article

9-Nitrocamptothecin as second line chemotherapy for men with progressive, metastatic, hormone refractory prostate cancer: results of the CALGB 99901AMIN, Asim; HALABI, Susan; GELMANN, Edward P et al.Urologic oncology. 2004, Vol 22, Num 5, pp 398-403, issn 1078-1439, 6 p.Article

Searching for the gatekeeper oncogene of prostate cancerGELMANN, Edward P.Critical reviews in oncology/hematology. 2003, Vol 46, pp S11-S20, issn 1040-8428, SUPConference Paper

Long-term outcomes after radical prostatectomy performed in a community-based health maintenance organizationYING ZHANG; GLASS, Andrew; BENNETT, Nicole et al.Cancer. 2004, Vol 100, Num 2, pp 300-307, issn 0008-543X, 8 p.Article

P53 gene mutations: Case study of a clinical marker for solid tumorsLIU, Minetta C; GELMANN, Edward P.Seminars in oncology. 2002, Vol 29, Num 3, pp 246-257, issn 0093-7754Article

Effect of homeodomain protein NKX3.1 R52C polymorphism on prostate gland sizeRODRIGUEZ ORTNER, Elizabeth; HAYES, Richard B; WEISSFELD, Joel et al.Urology (Ridgewood, NJ). 2006, Vol 67, Num 2, pp 311-315, issn 0090-4295, 5 p.Article

NKX3.1 Activates Expression of Insulin-like Growth Factor Binding Protein-3 to Mediate Insulin-like Growth Factor-l Signaling and Cell ProliferationMUHLBRADT, Erin; ASATIANI, Ekaterina; ORTNER, Elizabeth et al.Cancer research (Chicago, Ill.). 2009, Vol 69, Num 6, pp 2615-2622, issn 0008-5472, 8 p.Article

Relationship of demographic and clinical factors to free and total prostate-specific antigenGELMANN, Edward P; CHIA, David; LEVIN, David L et al.Urology (Ridgewood, NJ). 2001, Vol 58, Num 4, pp 561-566, issn 0090-4295Article

Design of the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening TrialPROROK, Philip C; ANDRIOLE, Gerald L; HAYES, Richard B et al.Controlled clinical trials. 2000, Vol 21, Num 6, pp 273S-309S, issn 0197-2456, SUPArticle

Mortality Results from a Randomized Prostate-Cancer Screening TrialANDRIOLE, Gerald L; GRUBB, Robert L; YOKOCHI, Lance A et al.The New England journal of medicine. 2009, Vol 360, Num 13, pp 1310-1319, issn 0028-4793, 10 p.Article

Genome-wide association study of prostate cancer identifies a second risk locus at 8q24YEAGER, Meredith; ORR, Nick; ZHAOMING WANG et al.Nature genetics. 2007, Vol 39, Num 5, pp 645-649, issn 1061-4036, 5 p.Article

A phase II study of mifepristone (RU-486) in castration-resistant prostate cancer, with a correlative assessment of androgen-related hormonesTAPLIN, Mary-Ellen; MANOLA, Judith; OH, William K et al.BJU international (Papier). 2008, Vol 101, Num 9, pp 1084-1089, issn 1464-4096, 6 p.Article

Prostate specific antigen changes as related to the initial prostate specific antigen : Data from the prostate, lung, colorectal and ovarian cancer screening trial. CommentaryCRAWFORD, E. David; PINSKY, Paul F; ROOBOL, Monique J et al.The Journal of urology. 2006, Vol 175, Num 4, pp 1286-1290, issn 0022-5347, 5 p.Conference Paper

Prostate cancer screening in the prostate, lung, colorectal and ovarian (PLCO) cancer screening trial : Findings from the initial screening round of a randomized trialANDRIOLE, Gerald L; LEVIN, David L; IZMIRLIAN, Grant et al.Journal of the National Cancer Institute. 2005, Vol 97, Num 6, pp 433-438, issn 0027-8874, 6 p.Article

Expression of genes and proteins specific for prostate cancer. DiscussionGELMANN, Edward P; SEMMES, O. John; ROSEN, Neal et al.The Journal of urology. 2004, Vol 172, Num 5, pp S23-S27, issn 0022-5347, 2Conference Paper

High NRBPI Expression in Prostate Cancer Is Linked With Poor Clinical Outcomes and Increased Cancer Cell GrowthRUIZ, Christian; OEGGERLI, Martin; KOIVISTO, Pasi A et al.The Prostate. 2012, Vol 72, Num 15, pp 1678-1687, issn 0270-4137, 10 p.Article

NKX3.1 homeodomain protein binds to topoisomerase i and enhances its activityBOWEN, Cai; STUART, August; JU, Jeong-Ho et al.Cancer research (Baltimore). 2007, Vol 67, Num 2, pp 455-464, issn 0008-5472, 10 p.Article

Repeat prostate biopsy in the Prostate, Lung, Colorectal and Ovarian cancer screening trialPINSKY, Paul F; CRAWFORD, E. David; KRAMER, Barnett S et al.BJU international (Papier). 2007, Vol 99, Num 4, pp 775-779, issn 1464-4096, 5 p.Article

Activation of signal transducer and activator of transcription-5 in prostate cancer predicts early recurrenceHONGZHEN LI; YING ZHANG; GLASS, Andrew et al.Clinical cancer research. 2005, Vol 11, Num 16, pp 5863-5868, issn 1078-0432, 6 p.Article

Transcription Factor Stat5 Synergizes with Androgen Receptor in Prostate Cancer CellsTAN, Shyh-Han; DAGVADORJ, Ayush; VISAKORPI, Tapio et al.Cancer research (Baltimore). 2008, Vol 68, Num 1, pp 236-248, issn 0008-5472, 13 p.Article